Chair, John C. Byrd, MD, and Kami Maddocks, MD, discuss B-cell cancers in this CME/MOC activity titled “Taking the Next Steps With Next-Generation BTK Inhibitors in CLL, MCL, and DLBCL.” For the full presentation and complete CME/MOC information, and to apply for credit, please visit us at http://bit.ly/3Gv1ZZ4. CME/MOC credit will be available until February 1, 2024.